상단영역
본문영역
reimbursement status 목록 ( 총 : 7건)
기사목록 보기 형태
-
Recordati Korea’s Isturisa and HLB Pharm’s Citirelin Added to Reimbursement List
이미지기사 제약 Sodam Park reporter 11.24 06:02 -
BeOne Medicine Launches Phase 3 Trial of BTK Degrader for CLL/SLL
이미지기사 제약 Sodam Park reporter 08.01 04:55 -
350 Years of Merck: Innovation and Focus on TGCT
이미지기사 제약 Sodam Park reporter 2024.12.25 15:23 -
Enhertu Coverage Starts April, Blood Tests Non-Reimbursable
이미지기사 보건의료 Sodam Park reporter 2024.04.05 05:58 -
Jeil Pharma’s Duglow Breakthrough in Diabetes Reimbursement
이미지기사 제약 Sodam Park reporter 2023.11.27 05:50 -
Bayer’s Jivi and Roche’s Vabysmo Included in Reimbursement Below Evaluation Amount
이미지기사 제약 Sodam Park reporter 2023.10.06 11:59 -
Coverage Uncertainty for Novo Nordisk’s Ozempic Diabetes Drug as Mounjaro’s Reimbursement Status Remains in Question
이미지기사 제약 Sodam Park reporter 2023.07.31 04:38